We are a biotech company that produces collagen-based biomaterials including highly purified medical-grade atelocollagen from animal tissue, to address emergent needs in the research and medical fields.
We aim to provide science-based solutions as the aging of the population presents new challenges to health and wellbeing and as medical research uncovers a growing list of ailments for which some form of collagen may be an effective option.
We work with our partners to provide problem solving expertise, design appropriate solutions and engineer high quality collagen products for specific customer-driven applications.
Founded in 2017 by a multidisciplinary team of scientists and entrepreneurs, Promed Bioscience aims to become a worldwide leader in the development, manufacture and supply of highly purified research and medical grade collagen from animal tissue.
Collagen products are extracted using proprietary methods under carefully controlled conditions in order to fit specific customer requirements of quality and suitability for a wide range of research, clinical and cosmetic/skincare applications.
There is a growing demand for collagen, propped by recent scientific discoveries into its role in health and disease, thus the company provides collagen-based formulations, biomaterials and devices customized for specific applications and sold through worldwide channels and partners.
Molecular biologist and biochemist with expertise in proteomics, stem cell and cancer biology, gene therapy, nanotechnology and drug discovery. Education in the UK: School of Medicine King’s College London, London School of Hygiene & Tropical Medicine, Germany: Hannover Medical School. Woman of the Year 2019 Nominee, Innovation Award, Madame Figaro Cyprus.
Biomedical engineer with expertise in preclinical drug development and advanced applications of biomaterials and nanotechnology in medicine. Mechanical and biomedical engineering studies in the USA: Harvard Medical School, MIT, Boston University. European Union Marie Curie Fellow at the Cyprus University of Technology.
A business executive and entrepreneur with significant expertise in operations, marketing and strategy. He is also a Certified Public Accountant (CPA). Education in the USA: MBA (Kellogg Graduate School of Management, Northwestern University)
Najy Alsayed, MD, M.SC., MBA, brings global medical and strategic expertise, defined by a patient centric mindset, developed within prestigious Pharma and academic institutions.
His over 25 years of experience and track records covers the innovative development, registration, partnering and launch of 7 major global brands. His expertise covers several disease areas, including Cardio-vascular, Immuno-oncology and infectious diseases at Pfizer, Novartis, Sanofi-Pasteur-MSD, CUBIST and MSD/Merck.
Prior to joining the pharma, he developed clinical and research expertise in internal medicine & nephrology and as a researcher in cardiovascular diseases at the INSERM in Paris-France and NIH in Bethesda-USA.